Acute Coronary Syndrome

Results of the late-breaking COLCOT trial, which explored the efficacy of low-dose colchicine in reducing CV risk in heart attack patients, were a highlight of the American Heart Association’s 2019 Scientific Sessions this month in Philadelphia.

Research out of Peking University in Beijing, China, has established a link between insomnia and heart disease, ABC News reports.

Millions of Americans are unaware of common heart attack symptoms, according to researchers, including a subset of 13.5 million people who admit to not knowing a single symptom of MI.

The FDA issued a safety communication Nov. 5 reminding the public, healthcare providers and lab workers that the common supplement vitamin B7, or biotin, can interfere with certain diagnostic tests, including troponin tests that can be integral to a heart attack diagnosis.

Facebook introduced a new tool this week that provides the platform’s users with personalized healthcare recommendations, CNN reports.

Cardiac care is suffering at hospitals that experience data breaches, PBS reported Oct. 24, with one study finding that heart attack rates soar in the weeks and months after a center’s cybersecurity is compromised.

A smartphone app introduced at the 45th Argentine Congress of Cardiology (SAC 2019) this week in Buenos Aires improved heart patients’ adherence to their drug regimen after a CV event.

An implantable cardiac monitor designed to alert patients with coronary artery disease to progressive, abnormal ST-segment shifts could expedite transport to the ED and reduce treatment delays during acute coronary syndromes, according to work published in the Journal of the American College of Cardiology.

A pooled analysis of 18 randomized trials has allowed researchers to unravel the so-called “smoker’s paradox,” proving that lighting up is an important risk factor for adverse events after PCI.

STEMI is increasingly prevalent among a growing population of patients in their nineties, according to a study published in the American Journal of Cardiology Oct. 11.

Using sex-specific thresholds for high-sensitivity cardiac troponin I assays identified five times more heart attacks in women in a recent study of patients with suspected ACS, but major disparities persisted when it came to treating MIs.

Cardiac radiation dose exposure is a modifiable cardiac risk factor for major cardiac adverse events and all-cause mortality in patients undergoing radiotherapy for non-small-cell lung cancer, researchers report in the Journal of the American Heart Association.